[HTML][HTML] KASL clinical practice guidelines: management of hepatitis C

Korean Association for the Study of the … - Clinical and …, 2016 - ncbi.nlm.nih.gov
Aims The Korean Association for the Study of the Liver (KASL) Practice Guidelines for
Management of Hepatitis C were first established in 2004, and revised in 2013, when direct …

[HTML][HTML] Genetic variation of hepatitis B virus and its significance for pathogenesis

ZH Zhang, CC Wu, XW Chen, X Li, J Li… - World journal of …, 2016 - ncbi.nlm.nih.gov
Hepatitis B virus (HBV) has a worldwide distribution and is endemic in many populations.
Due to its unique life cycle which requires an error-prone reverse transcriptase for …

[HTML][HTML] KASL clinical practice guidelines: management of chronic hepatitis B

Korean Association for the Study of the … - Clinical and …, 2012 - ncbi.nlm.nih.gov
The guideline on the management of chronic hepatitis B (CHB) was first developed in 2004
and revised in 2007 by the Korean Association for the Study of the Liver (KASL). Since then …

How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation

R Liang - Blood, The Journal of the American Society of …, 2009 - ashpublications.org
Hepatitis B virus (HBV) reactivation is a serious but preventable complication of
immunosuppression. Full HBV serologic profile must be obtained from all patients receiving …

Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg‐negative and anti‐HBc antibodies‐positive patients undergoing chemotherapy …

P Borentain, P Colson, D Coso, E Bories… - Journal of viral …, 2010 - Wiley Online Library
We studied clinical outcome and clinico‐virological factors associated with hepatitis B virus
reactivation (HBV‐R) following cancer treatment in hepatitis B virus surface antigen (HBsAg) …

Chronic hepatitis B infection

A Kuo, R Gish - Clinics in liver disease, 2012 - liver.theclinics.com
An estimated 350 to 400 million people worldwide are chronically infected with hepatitis B
virus (HBV). The greatest burden of disease lies in Asia, where 75% of infected persons …

The safety profile of cyclophosphamide in multiple sclerosis therapy

P Perini, M Calabrese, L Rinaldi… - Expert Opinion on Drug …, 2007 - Taylor & Francis
Cyclophosphamide (Cyc) is an alkylating agent used to treat malignancies and autoimmune
diseases, such as lupus nephritis, rheumatoid arthritis and immune-mediated neuropathies …

Immunosuppression in patients with chronic hepatitis B

A Seetharam, R Perrillo, R Gish - Current hepatology reports, 2014 - Springer
After hepatitis B virus (HBV) infection, HBV DNA persists in minute amounts in hepatocyte
nuclei even in individuals with “resolved” infection. Viral replication and development of liver …

Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants

A Mühlbacher, B Weber, P Bürgisser, A Eiras… - Medical microbiology …, 2008 - Springer
In a multicenter study a new, fully automated Roche Diagnostics Elecsys® HBsAg II
screening assay with improved sensitivity to HBsAg mutant detection was compared to well …

[HTML][HTML] Chemotherapy-related reactivation of hepatitis B infection: updates in 2013

HY Kim, W Kim - World Journal of Gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Hepatitis B reactivation is a potentially serious complication of anticancer chemotherapy,
which occurs during and after therapy. This condition affects primarily hepatitis B surface …